A carregar...

Atenolol and bendrofluazide in hypertension.

The effect of atenolol, a new beta-1-adrenergic receptor blocking agent, was studied in a double-blind cross-over trial in 24 carefully selected hypertensive outpatients. After a four-week run-in period on matching placebo each patient received atenolol 200 mg/day, atenolol 400 mg/day, a combination...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Petrie, J C, Galloway, D B, Webster, J, Simpson, W T, Lewis, J A
Formato: Artigo
Idioma:Inglês
Publicado em: 1975
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1674832/
https://ncbi.nlm.nih.gov/pubmed/1104047
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!